Karolina Hanna Prazanowska

Karolina Hanna Prazanowska

Auto-generated profile, based on publicly available information

Karolina Hanna Prazanowska

Department of Biochemistry & Molecular Biology, Ajou University School of Medicine, Suwon, South Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2023 in Scientific Data
Verified
Journal Article
Open access
PDF file
KPKarolina Hanna Prazanowska
Karolina Hanna Prazanowska
SLSu Bin Lim
Su Bin Lim
As single-cell RNA sequencing (scRNA-seq) has emerged as a great tool for studying cellular heterogeneity within the past decade, the number of available scRNA-seq datasets also rapidly increased. However, reuse of such data is often problematic due to a small cohort size, limited cell types, and insufficient information on cell type classification. Here, we present a large integrated scRNA-seq dataset containing 224,611 cells from human primary non-small cell lung cancer (NSCLC) tumors. Using publicly available resources, we pre-processed and integrated seven independent scRNA-seq datasets using an anchor-based approach, with five datasets utilized as reference and the remaining two, as validation. We created two levels of annotation based on cell type-specific markers conserved across the datasets. To demonstrate usability of the integrated dataset, we created annotation predictions for the two validation datasets using our integrated reference. Additionally, we conducted a trajectory analysis on subsets of T cells and lung cancer cells. This integrated data may serve as a resource for studying NSCLC transcriptome at the single cell level.

30 January 2025 in Scientific Data
Verified
Journal Article
Open access
PDF file
KPKarolina Hanna Prazanowska
Karolina Hanna Prazanowska
TKTae-Hun Kim
Tae-Hun Kim
JKJung Won Kang
Jung Won Kang
YJYoung-Hee Jin
Young-Hee Jin
SKSunoh Kwon
Sunoh Kwon
SLSu Bin Lim
Su Bin Lim
Following the coronavirus disease 2019 (COVID-19) pandemic, the rise of long COVID, characterized by persistent respiratory and cognitive dysfunctions, has become a significant health concern. This leads to an increased role of complementary and alternative medicine in addressing this condition. However, our comprehension of the effectiveness and safety of herbal medicines for long COVID remains limited. Here, we present a single-cell RNA sequencing (scRNA-seq) dataset of peripheral whole blood cells derived from participants in a clinical study involving three commercially available herbal medicines, targeting fatigue and brain fog in long COVID. The dataset comprises 181,205 quality control (QC)-passed cells, along with clinical metadata, enabling a comparative analysis of immune cell populations before and after treatment. To ensure the technical validity of our dataset, we implemented rigorous quality checks throughout stages of the study, including sample preparation, sequencing, and bioinformatic data analysis levels. This transcriptomic data may serve as a resource to deepen our insights into the role of herbal medicines in management of long COVID.

9 May 2022 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
KWKlaudia Waszczykowska
Klaudia Waszczykowska
KPKarolina Prażanowska
Karolina Prażanowska
Żaneta Kałuzińska-KołatŻaneta Kałuzińska-Kołat
Żaneta Kałuzińska-Kołat
Damian KołatDamian Kołat
Damian Kołat
Elżbieta PłuciennikElżbieta Płuciennik
Elżbieta Płuciennik